Products transform the way critical diseases like cancer are known
and treated
NantHealth to exhibit in booth #5561 and provide live demos on the
Interoperability Showcase™ Floor
ORLANDO, Fla.--(BUSINESS WIRE)--
NantHealth,
Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized
healthcare company, announced today that it will be exhibiting its new
suite of oncology solutions at booth #5561 and providing demos at the
Interoperability Showcase floor at booth #9000 Hall F, during the HIMSS
2017 Annual Conference & Exhibition in Orlando, Florida.
Recognized as one of the premiere healthcare industry conferences,
HIMSS17 brings together healthcare professionals from across the globe.
Throughout HIMSS 2017, NantHealth will showcase its extensive Oncology
Suite aimed at improving the effectiveness and efficiency of specialty
care through clinical and IT solutions. The solution takes a holistic
approach to patient care via molecular profiling, precision medicine
decision support, care coordination and outcomes measurement providing a
continuous feedback loop which supports the goal of higher quality care
at a reduced cost. The solutions also support the Centers for Medicare &
Medicaid Services’ (CMS) Innovation Center’s Oncology
Care Model (OCM) program. The goal of the OCM is to achieve better
care, smarter spending and healthier people. To support this model,
NantHealth’s portfolio of solutions provides oncologists with the tools
necessary to ensure that 21st century treatments are
deployed across the country.
Among its suite of next-generation solutions is NantHealth’s latest
rendition of the Vitality®
Glowcap®, a medication adherence system that tracks, reminds and
alerts patients to reinforce them to take their prescribed medication,
which now utilizes Bluetooth Low Energy (BLE) 4.0 communications. As the
pace of technology innovation in healthcare continues to gain momentum,
connected care has become critical to improving the patient experience,
as it ensures a seamless delivery of health IT services at the point of
care.
In addition to showcasing this latest connected care solution,
NantHealth will also be exhibiting the following solutions at booth
#5561:
-
Oncology Solutions
-
GPS
Cancer™: a comprehensive molecular profile providing key
insights based on the unique biology of a patient’s tumor—from the
DNA to the RNA to the protein.
-
eviti®:
the evidence-based treatment intelligence and web-based oncology
decision support platform, which was recently named #1
Clinical Decision Support solution for 2016 by Black Book
Market Research.
-
Patient-Provider Engagement Solution
-
Health Notebook: connects patients with their providers and health
records to improve satisfaction and motivate patients to
participate in their own care.
-
Care
Coordination: helps clinicians manage patient care across
multiple care settings.
-
Provider
Portal: gives physicians a unified view of critical patient
data across the enterprise, across the continuum, across the
episode of care—despite disparate systems and varying locations.
-
Connected Care Solutions
-
DeviceConX®:
captures patient data from medical devices, and delivers that data
to an EHR, CIS, or other data repository—quickly and accurately.
-
VitalsConX®:
a flexible, intuitive rounding solution that automates a patient’s
vitals collection workflow.
-
Payer Engagement Solutions
-
NaviNet®
Open: the industry’s leading payer-provider collaboration
platform.
While at the Interoperability Showcase in kiosk #9000 Hall F, NantHealth
will demonstrate joint use cases led by HealthShare Exchange of
Southeastern PA with Independence Blue Cross, University of
Pennsylvania, NextGen and Comcast called “On the Road to Cancer Care
2020” addressing how technology will impact the future of cancer
treatment. NantHealth will also deliver a “Scheduled Surgery and
Recovery” use case with several key industry stakeholders, which follows
a patient from a scheduled surgery through recovery demonstrating how
interoperability is present throughout the journey. Additional use cases
being displayed include:
-
i-Home Use Case: featuring NantHealth’s Care Coordination and
Vitality solutions.
-
Outpatient Use Case: highlighting EMR integration with eviti
cancer clinical learning solution.
-
OR Use Case: demonstrating the Connected Care DeviceConX
solution.
-
IoT Demo Wall: demonstrating the state-of-the-art Connected
Care Vitality solution for medication adherence.
“As we continue on the path toward advancing cancer care, we’re
constantly thinking about the ecosystem of influence that will help us
achieve this goal,” said Dr. Patrick Soon-Shiong, CEO and founder of
NantHealth. “Whether its personalized medicine identified via GPS Cancer
or enabling providers to have access to treatment intelligence
databases, there are many components that are responsible for working
together to find the ways we can fight this longstanding battle against
cancer. Health IT certainly plays a major role in connecting payers,
providers and patients and it is a necessity if we’re ever going to
defeat this disease.”
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, among others, statements regarding the capabilities and
anticipated utility of our GPS Cancer, including predicting patient
response and resistance to therapeutics, enabling diagnoses by
physicians and accelerating efforts to bring novel combinations of
therapeutic agents to cancer patients. Forward-looking statements are
subject to numerous risks and uncertainties that could cause actual
results to differ materially from currently anticipated results. Factors
that may cause future results to differ materially from management’s
current expectations include, among other things, that GPS Cancer may
not perform as anticipated, that sufficient physicians may not adopt GPS
Cancer to assist their diagnoses or that healthcare payers may not
provide reimbursement for GPS Cancer as expected. Our business is
subject to numerous additional risks and uncertainties, including, among
others, risks relating to market acceptance of our products; our ability
to successfully launch new products and applications; competition; our
sales, marketing and distribution capabilities; our planned sales,
marketing, and research and development activities; unanticipated
increases in costs or expenses; and risks associated with international
operations. Information on these and additional risks, uncertainties,
and other information affecting our business and operating results can
be found in our existing and future filings with the Securities and
Exchange Commission. These forward-looking statements speak only as of
the date hereof. We disclaim any obligation to update these
forward-looking statements except as may be required by law.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a
next-generation, evidence-based, personalized healthcare company
enabling improved patient outcomes and more effective treatment
decisions for critical illnesses. NantHealth’s unique systems-based
approach to personalized healthcare applies novel diagnostics tailored
to the specific molecular profiles of patient tissues and integrates
this molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system, CLINICS, which includes its
unique software, middleware and hardware systems infrastructure that
collects, indexes, analyzes and interprets billions of molecular,
clinical, operational and financial data points derived from novel and
traditional sources, continuously improves decision-making and further
optimizes our clinical pathways and decision algorithms over time. For
more information please visit www.nanthealth.com
and follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170220005157/en/
NantHealth
Jen Hodson, 562-397-3639
jhodson@nantworks.com
Source: NantHealth, Inc.